subslover
2 años hace
STRATA Skin Sciences Announces U.S. Commercial Launch of TheraClear®X Acne Therapy System
July 25 2022 - 04:01PM
GlobeNewswire Inc.
Alert
Print
Tweet Share On Facebook
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the U.S. commercial launch of TheraClear®X, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular and inflammatory acne vulgaris.
“We’re delighted to have reached this milestone in bringing TheraClearX to the U.S. market. We are confident that this technology will offer an exciting new treatment option for acne patients and dermatology professionals, as well as deliver an exciting new growth opportunity for STRATA,” said CEO Bob Moccia. “We are especially excited to now offer an acne treatment through STRATA’s well established “Partnership Program” which offers dermatology practices in the U.S. practical in-office treatment solutions without the need to purchase expensive equipment.”
The TheraClearX Acne Therapy System is engineered and indicated specifically for the treatment of acne. By combining vacuum technology and intense broadband light (500nm-1200nm), TheraClearX shows significant promise in the fight against acne. For best results, it is recommended patients complete 4-6 treatment sessions (scheduled 1-2 weeks apart), dependent on acne severity. Treatments can be completed in 15-20 minutes and are pain-free.
“TheraClearX’s photopneumatic technology, combining vacuum extraction with light therapy, is a proven technology with scientifically published evidence of success in treating acne. TheraClearX helps us simultaneously address multiple treatment goals. For example, removing and clearing acne-causing bacteria, clearing out occluded pores and reducing sebum production can all be achieved with this device,” said Gilly S. Munavalli, MD, MHS, FACMS, Medical Director and founder of Dermatology, Laser & Vein Specialists of the Carolinas in Charlotte, NC. “We have had the opportunity to treat a sizeable number of patients with this technology over an extended period of time and consider this to be amongst the most effective medical devices available to treat and resolve acne.”
STRATA is leveraging its national salesforce and commercial team to bring TheraClearX to the U.S. market, while currently exploring strategic partners internationally.
To learn more about TheraClearX, please visit www.theraclearx.com
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC® and Pharos® excimer lasers, VTRAC® lamp systems, and now the TheraClear®X Acne Therapy System.
STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the
georgie18
3 años hace
SSKN...$1.33...STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems
Positions STRATA as the predominant provider of excimer laser treatments to address the $6 billion U.S. market for the treatment of chronic skin diseases
Delivers added long-term recurring revenue growth potential and prospective customer base
Increases competitive positioning with more than 400 U.S. dermatology practices
HORSHAM, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the acquisition of the U.S. dermatology business of Ra Medical.
The transaction immediately provides STRATA with the opportunity to market its full business solution to Ra Medical’s existing customer base of 400 dermatology practices, thus making way for STRATA to substantially increase its recurring revenue base in the future. It also provides a highly synergistic path to gain additional placements for STRATA’s XTRAC excimer laser system...